THE MODULATION OF FLUOROURACIL WITH LEUCOVORIN IN METASTATIC COLORECTAL-CARCINOMA - A PROSPECTIVE RANDOMIZED PHASE-III TRIAL

被引:582
作者
PETRELLI, N
DOUGLASS, HO
HERRERA, L
RUSSELL, D
STABLEIN, DM
BRUCKNER, HW
MAYER, RJ
SCHINELLA, R
GREEN, MD
MUGGIA, FM
MEGIBOW, A
GREENWALD, ES
BUKOWSKI, RM
HARRIS, J
LEVIN, B
GAYNOR, E
LOUTFI, A
KALSER, MH
BARKIN, JS
BENEDETTO, P
WOOLLEY, PV
NAUTA, R
WEAVER, DW
LEICHMAN, LP
机构
[1] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, BUFFALO, NY 14263 USA
[2] MT SINAI MED CTR, NEW YORK, NY 10029 USA
[3] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA
[4] NYU, NEW YORK, NY 10003 USA
[5] MONTEFIORE MED CTR, BRONX, NY 10467 USA
[6] CLEVELAND CLIN, CLEVELAND, OH 44106 USA
[7] UNIV CHICAGO, ILLINOIS CANC CTR, CHICAGO, IL 60637 USA
[8] MCGILL UNIV, CTR CANC, MONTREAL H3A 2T5, QUEBEC, CANADA
[9] UNIV MIAMI, MIAMI, FL 33152 USA
[10] GEORGETOWN UNIV, WASHINGTON, DC 20057 USA
[11] WAYNE STATE UNIV, DETROIT, MI 48202 USA
关键词
D O I
10.1200/JCO.1989.7.10.1419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1419 / 1426
页数:8
相关论文
共 31 条
[1]  
ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO
[2]  
2-2
[3]  
BRUCKNER HW, 1982, P AM ASSOC CANC RES, V23, P111
[4]  
BRUCKNER HW, 1981, P AM ASSOC CANC RES, V22, P192
[5]  
BRUCKNER HW, 1983, P AM ASSOC CANC RES, V23, P138
[6]  
BRUCKNER HW, 1984, ADV CANCER CHEMOTHER, P49
[7]   5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - A RANDOMIZED COMPARISON - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].
BUDD, GT ;
FLEMING, TR ;
BUKOWSKI, RM ;
MCCRACKEN, JD ;
RIVKIN, SE ;
OBRYAN, RM ;
BALCERZAK, SP ;
MACDONALD, JS .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :272-277
[8]   EARLY DECISION IN CLINICAL-TRIALS WHEN THE TREATMENT DIFFERENCES ARE SMALL - EXPERIENCE OF A CONTROLLED TRIAL IN HEAD TRAUMA [J].
CHOI, SC ;
SMITH, PJ ;
BECKER, DP .
CONTROLLED CLINICAL TRIALS, 1985, 6 (04) :280-288
[9]  
DOROSHOW JH, 1987, P AN M AM SOC CLIN, V6, P96
[10]  
ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147